Valneva announced the appointment of two leading vaccine experts to its Scientific Advisory Board (SAB). Dr. Stanley A. Plotkin, MD and Dr. Anna Durbin, MD, have joined Valneva’s SAB.
Toggle Navigation
- Research
Back- Research at Vienna BioCenter
- Research Entities
- Research AreasResearch AreasOpen SubmenuBack
- Anthropogenic Evolution
- Biochemistry, Biophysics, Structure
- Cell and Chromosome Biology
- Cognitive and Behavioral Biology
- Computational Biology, Genomes and Evolution
- Disease Mechanisms, Immunology, Pathogens
- Gene Regulation, RNA, Epigenetics
- Microbiology and Environmental Systems Science
- Neurobiology
- Plant Sciences
- Stem Cells, Development, Regeneration
- Research Groups
- Key DiscoveriesKey DiscoveriesOpen Submenu
- Recent Research Highlights
- Covid-19Covid-19Open Submenu
- VBCF
- CompaniesBack
- Companies at Vienna BioCenter
- Biotech CompaniesBiotech CompaniesOpen SubmenuBack
- a:head
- Ablevia Biotech
- ACCANIS Biotech
- ADvantage Therapeutics
- Affiris AG in Liqu
- Akribes
- Ares Genetics
- Austrianni
- BioNTech R&D Austria
- Bird-C
- bit.bio discovery GmbH
- CALYXHA Biotechnologies
- ChanPharm
- EUCODIS Bioscience
- Eveliqure
- Evercyte
- Exscientia
- G.ST Antivirals
- Haplogen
- Hookipa Pharma
- invIOs
- JLP Health
- Lexogen
- Miti Biosystems
- MyeloPro Diagnostics and Research GmbH
- Myllia Biotechnology
- OncoOne
- Origimm
- Phenaris
- Pregenerate
- Proxygen
- QUANTRO Therapeutics
- SCARLETRED
- TAmiRNA
- Thermo Fisher Scientific
- Tridem Bioscience
- Valneva
- X4 Pharmaceuticals
- YGION Biomedical GmbH
- Service CompaniesService CompaniesOpen Submenu
- Business IncubatorsBusiness IncubatorsOpen Submenu
- Scientific AssociationScientific AssociationOpen Submenu
- Education
- Career
- About